HomeSite MapCustomer Logon
 Dialog1
 DialogClassic
 DialogPRO
 DialogSelect
 DialogWeb
 ProQuest Dialog
Authoritative Answers for Professionals
Follow Dialog on Twitter  Follow Dialog on Facebook  Join Dialog on LinkedIn  You Tube e-Newsletters  RSS Feeds  Share

Reloaded Adis R&D Insight on ProQuest Dialog contains new data

Adis R&D Insight, a database of approximately 30,000 records, was reloaded recently with new data. 

  • Full text:  More full text including Probability of Approvals data, Revenue Forecast data, Tables of History of Drug Development (Development History), Development Phases and Images, when available, appearing toward the end of the full text
  • Drug status:  Active or Inactive
  • Trade name:  Followed by its related Indication, Country (Region) and Company
  • Indication:  Shown and searchable
  • Origin of substance:  Used to indicate whether or not the drug is a fixed combination
  • Pharmacokinetics:  Characteristics and Efficacies now visible 
  • Phase:  Table of Development Phases in the lower part of the full-text area showing both existing items (phase, country(region), and the indication) and additional items (Route of Administration, Formulation, On Fast Track indicator and “Qualifiers and Comments”). Combine items using the LNK operator, for example, phase with indication or country (e.g., “phase i” lnk asthma lnk japan).
  • Development history:  Table of History of Drug Development in the lower part of the full-text area showing both existing items (Event Date and Details) and additional items (Update Date, Update Type, and an indicator of whether the event is significant) 
  • Accession number:  Accession numbers no longer six digits so they do not need preceding zeroes. For example, the old accession number 021783 is now just 21783.

SEPTEMBER 2012

top

 
  ProQuest   |   About Us   |   Site Search   |   Site Map  
Copyright Notices   |   Terms of Use   |   Privacy Statement